One hundred ninety-five rabies cases in cattle were identified in South Korea since 1993. As most of rabies cases have a relation to rabid Korean raccoon dogs (Nyctereutes procyonoides koreensis), vaccination to animals including cattle is mandatory in rabies risk region. In order to minimize fatal rabies in animals, eradication policy of the disease has been achieved by controlling reservoirs and by mass vaccination. In this study, we compared the antibody response in cattle and guinea pigs inoculated with rabies vaccines commercially available in Korea. Each group of cattle in Gangwon-do was vaccinated intramuscularly with either one of five commercial inactivated vaccines or a live attenuated rabies vaccine (designated as A to F). Serum samples at the time of vaccination and four weeks post vaccination were obtained from the cattle and guinea pigs and were analyzed with virus neutralizing assay (VNA). Each group of cattle inoculating rabies vaccines showed significant virus neutralizing antibody titers (p < 0.05) ranging from 1.55 to 17.8 mean IU/ml compared with the non-vaccinated cattle and guinea pigs inoculated with 1/20 dose of vaccine showed relatively low VN antibody titers ranging from 0.23 to 6.1 mean IU/ml. All cattle immunized with A, C and F showed high VN antibody titers over 0.5 IU/ml and 62.5% and 37.5% of cattle inoculated with D and E showed protective antibody titer, respectively. This finding suggests that the inactivated or live attenuated rabies vaccination commercially available in Korea could induce protective antibody response in Korean cattle, but sero-conversion rate and sero-positive rate showing VN antibody titer over 0.5 IU/ml depend on vaccines.
INTRODUCTION
Rabies is a fatal zoonosis that occurs in more than 150 nations around the world and is claiming lives of 55,000 people annually (1) . Rabies is transmitted to all kinds of warm blooded animals by rabid animals in various regions of the world. In Latin America, vampire bat (Desmodus rotundus) takes responsibility for transmitting the disease to livestock; in Europe, wild animals such as foxes play a key role transmitting the disease; in several countries including India and Thailand, dogs are considered as major vector species, and in Korea, raccoon dogs (Nyctereutes procyonoides koreensis) and badger (Meles meles) are the major source of transmission (2~6).
Cattle are known to be highly susceptible to rabies. lactation, increased interest with sound or light and paralysis of the throat. In the furious form of rabies, cattle may try to attack humans or other animals. Late clinical signs can include opisthotonus, seizures, and widespread paralysis (7) .
In general, death occurs soon after late clinical signs.
Since the rabies case was reported again in dogs in 1993, a number of rabies cases in Korea have been identified in several animal species such as dogs, cattle, raccoon dogs and cats at only two provinces (Gyeonggi-do and Gangwon-do) until 2013 (8, 9) . The number of cattle infected by rabies in 
MATERIALS AND METHODS

Vaccines
The five inactivated rabies vaccines and one attenuated rabies vaccine were used in this study as follows: Nobivac 
Serological assay
Virus neutralizing assay (VNA) was determined by the fluorescent antibody virus neutralization (FAVN) test (19) . 
Identification of antigen in vaccines
One milliliter of rabies vaccine was put in tube and centrifuged at 7,000 x g for 5 min and the supernatant was 
Statistical analysis
Statistical significance was assessed with one-way analysis of variance (ANOVA) for comparisons among vaccine groups. A value of p < 0.05 was considered statistically significant.
RESULTS
Immune response of rabies vaccines in animals
None 2B ). On the other hand, non-vaccinated cattle and guinea pigs remained sero-negative against rabies at all times.
Identification of RABV antigen in vaccines
The supernatant of centrifuged rabies vaccine and the sodium citrate treated supernatant were run on polyacrylamide SDS gels and followed by Western blotting assay with specific monoclonal antibody against G protein of RABV. Western blot assay revealed that sodium citrate treated supernatants showed better reaction than that of non-treated supernatant. Vaccine B, C, and E showed strong reaction (65 kDa) with RABV monoclonal antibody (Fig. 3) . A B Figure 3 . Western blot and Coomassie blue staining to check glycoprotein in commercial RABV vaccines. Developed membranes of native condition with the supernatant of RABV vaccine (A) and sodium citrate treated supernatant (B), and Coomassie blue stained SDS/PAGE gels (C) of RABV vaccines. After treating vaccines with sodium citrate, each total protein of vaccine was found to be 1.9 mg/ml, 5.29 mg/ ml, 3.41 mg/ml, 2.35 mg/ml, 4.9 mg/ml and 1.47 mg (26) . In our study, G protein in three inactivated rabies vaccines was identified using Western blotting (WB) assay. However, G protein of other three vaccines was not detected when treated with sodium citrate. In this study, we were not able to verify the reason why the G protein from vaccine A, the strongest antibody inducer, was not detected in WB assays. It could be due to different vaccine strain, adjuvant concentration, monoclonal antibody as detector, or antigen extraction method with sodium citrate. As the G protein from all kinds of inactivated RABV vaccines could not be detected in WB assay, other reagent such as isopropyl myristate may be applicable for extracting antigen from adjuvant within vaccines (15) . Additional studies are needed to solve this problem. As the method of ELISA for in vitro potency test of rabies vaccines was evaluated (12) , ELISA can be used to quantify the viral antigens in the rabies vaccines.
DISCUSSIONS
In conclusion, half of commercial rabies vaccines tested in this study cannot induce protective immune response in Korean Hanwoo cattle after vaccination, therefore, it is recommended that booster vaccination is needed for complete herd immunity. The guinea pigs may be useful animals in predicting immune response of rabies vaccine.
In addition, development of alternative testing method in vitro is required for the quality control of inactivated rabies vaccine.
